Clinical Trial Update: Randomized Phase III Trial Comparing Sequential Administration of FE75C Followed by Docetaxel Versus Paclitaxel as Adjuvant Chemotherapy in Axillary Lymph Node (+) Breast Cancer [Phase 3]

View source ↗

Summary

A Phase III randomized trial comparing sequential FE75C followed by Docetaxel versus Paclitaxel as adjuvant chemotherapy for axillary lymph node-positive breast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• FE75C
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Hellenic Oncology Research Group | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED